Joanne Billings - Concepedia

Author

Joanne Billings

Also Known As

Ella Kazerooni, H. Benamer, J Billings, J. Billings, J.L. Billings, JoAnne Billings, Joanne Billings, Joanne L Billings, Joanne L. Billings, Joseph M. Pilewski

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

University of Minnesota University of Colorado Denver National Jewish Health University of Alabama at Birmingham Brigham and Women's Hospital

About

Joanne Billings is an author at University of Minnesota specializing in medicine, pulmonary disease, and pulmonary medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	1.2K
2	Public Health	4	4	156
3	Biostatistics	2	2	63
4	Social Sciences	1	1	17
5	Allergy	1	1	53

Joanne Billings

Publications

Citations

H-Index

Page 1

	Year	Citations
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta, New England Journal of Medicine	2020	1.9K
Phase II studies of nebulised Arikace in CF patients with<i>Pseudomonas aeruginosa</i>infection John P. Clancy, Lieven Dupont, Michael W. Konstan, Thorax	2013	218
Diabetes Is Associated With Dramatically Decreased Survival in Female but Not Male Subjects With Cystic Fibrosis Carlos Milla, Joanne Billings, Antoinette Moran Diabetes Care	2005	207
Respiratory viruses and chronic rejection in lung transplant recipients Joanne Billings The Journal of Heart and Lung Transplantation TransplantationRespiratory DiseasesRespiratory VirusesMedicineImmunology	2002	198
Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study Melena D. Bellin, Theresa A. Laguna, Janice Leschyshyn, Pediatric Diabetes	2013	188
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson, The Lancet Respiratory Medicine Long CovidClinical TherapeuticCovid-19 PandemicBaricitinib Versus DexamethasoneClinical Trials	2022	127
Lung Function and Ischemic Stroke Incidence Atsushi Hozawa, Joanne Billings, Eyal Shahar, CHEST Journal Ischemic Stroke IncidenceIschemic StrokeCardiovascular DiseaseMedicineCerebrovascular Disease	2006	118
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell, The Lancet Respiratory Medicine MedicineHypertonic SalineDornase AlfaPulmonary Fibrosis	2022	116
High Prevalence of Proximal and Distal Gastroesophageal Reflux Disease in Advanced COPD Robert R. Kempainen, Kay Savik, Timothy P. Whelan, CHEST Journal EsophagusAdvanced Lung DiseaseGastroenterologyHigh PrevalenceAdvanced Copd	2007	101
Disease Progression Modeling in Chronic Obstructive Pulmonary Disease Alexandra L. Young, Felix Bragman, Bojidar Rangelov, American Journal of Respiratory and Critical Care Medicine	2019	99

Page 1